Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/8/2025

Initial Treatment for Mixed Stress and Urge Incontinence

Diagnostic Confirmation Required Before Treatment

  • The American Urological Association recommends characterizing the specific incontinence pattern by asking whether leakage occurs with coughing/sneezing/exercise (stress) versus preceded by sudden compelling urge (urge component) 3, 4
  • The American Urological Association suggests measuring post-void residual volume via bladder scan or catheterization to exclude overflow incontinence, which would completely change management 1, 2
  • Obtaining urinalysis is recommended to rule out infection, hematuria, or glucosuria that may mimic or worsen symptoms 4, 2
  • Assessing symptom bother and quality of life impact, including limitations on social activities, work, and sexual function, is crucial 3, 2

First-Line Conservative Treatment Algorithm

  • The American College of Obstetricians and Gynecologists recommends weight loss in obese women, which provides significant improvement particularly for the stress component 5, 1
  • Addressing modifiable factors, including smoking, diabetes control, depression, constipation, and medications that worsen incontinence, is essential 4

Second-Line Pharmacologic Treatment

  • The American Urological Association suggests adding antimuscarinic medications, such as tolterodine, for the urge component, which are FDA-approved for overactive bladder with urge urinary incontinence, urgency, and frequency 5, 1
  • Expect modest absolute benefit with less than 20% absolute risk difference over placebo 5, 1
  • Monitoring closely for side effects, including dry mouth, constipation, cognitive changes, and urinary retention, is necessary 5, 2

Important Clinical Pitfalls

  • The American Urological Association recommends never proceeding to surgical treatment without first confirming the incontinence type through history, physical exam, and post-void residual measurement 1
  • Approximately 30-50% of women have mixed incontinence, requiring combined treatment approaches rather than addressing only one component 4
  • Do not overlook treatable causes, including vaginal atrophy, undiagnosed diabetes, or constipation, particularly in older women 4

Indications for Further Testing or Referral

  • Consider urodynamic testing or specialist referral if initial management fails after adequate trial 1
  • Hematuria on urinalysis is an indication for further testing or referral 4
  • Significant post-void residual volume is an indication for further testing or referral 4
  • Grade III or greater pelvic organ prolapse is an indication for further testing or referral 6

Surgical Options (After Conservative Failure)

  • Synthetic midurethral mesh slings achieve 48-90% symptom improvement with less than 5% mesh complications 1, 2

REFERENCES

2

Urgency and Urge Incontinence Evaluation in Women [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3

Treatment of Urinary Incontinence [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Diagnostic Evaluation and Management of Urinary Incontinence [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025